Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
CLONEVAX from Deinze, company number BE0874375915, closed financial year 2024 with a result of € 16,271 after tax. For that financial year CLONEVAX recorded a gross margin of € 18,843 and equity of € 326,944. Compared with financial year 2023, the result moved from € 11,128 to € 16,271. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2025.
€ 326,944
▲ 5% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16,271
▲ 46% vs 2023
Profit after tax over the fiscal year.
€ 20
▲ € 17 vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 308,344.
People and assets in 2024
€ 6,826
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 34,528
▲ 36% vs 2023
€ 6,928 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 4,857
▼ 47% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 10,207
▲ 7% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 2,746 | € 11,957 | € 18,843 | ▲ 58% |
| Profit after taxes | € 10,095 | € 11,128 | € 16,271 | ▲ 46% |
| Equity | € 299,545 | € 310,673 | € 326,944 | ▲ 5% |
| Total debts | € 31,973 | € 44,078 | € 49,592 | ▲ 13% |
| Cash | € 26 | € 3 | € 20 | ▲ € 17 |
| Retained profit | € 280,945 | € 292,073 | € 308,344 | ▲ 6% |
| Bank debt | € 0 | € 25,443 | € 34,528 | ▲ 36% |
| Balance sheet total | € 331,518 | € 354,751 | € 376,536 | ▲ 6% |
Key figures of CLONEVAX, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.
What happened to CLONEVAX?
What happened at CLONEVAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
CLONEVAX is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2024: profit of € 16,271 (▲ 46% vs 2023). Source: NBB ↗
- WIM DE MAERTELAERE became a director. NBB
- New establishment in Deinze. KBO
- Start of the company according to the CBE. KBO
In short
From € 10,095 profit in 2022 to € 16,271 profit in 2024.
Paid € 21,776 in corporate taxes since 2022.
Best year ever: 2024, with € 16,271 profit.
A new publication or filing at CLONEVAX? We notify you, reason included.
Follow CLONEVAXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
WIM DE MAERTELAERE
bestuurder
since 2024
Establishments
Establishment units
Physical locations of this company
Leernsesteenweg 173 box E
9800 Deinze
Edekestraat 89
9800 Deinze
Active since 24 June 2005
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.375.915
- VAT number
- BE 0874.375.915
- Registered office
- Leernsesteenweg 173 bus E, 9800 Deinze
- Names & denominations
- CLONEVAX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 30 May 2005
- Peppol
- Active · Active since 3 Feb 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computeradviesbureaus
Computerconsultancy-activiteiten